115 related articles for article (PubMed ID: 1555210)
1. Effects of tyrosinase activity on the cytotoxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol in melanoma cells.
Prezioso JA; Epperly MW; Wang N; Bloomer WD
Cancer Lett; 1992 Mar; 63(1):73-9. PubMed ID: 1555210
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.
Prezioso JA; Wang N; Bloomer WD
Cancer Chemother Pharmacol; 1992; 30(5):394-400. PubMed ID: 1505078
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
4. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Alena F; Iwashina T; Gili A; Jimbow K
Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
[TBL] [Abstract][Full Text] [Related]
5. Effects of tyrosinase activity on the cytotoxicity of 3,4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells.
Prezioso JA; Fitzgerald GB; Wick MM
Pigment Cell Res; 1990; 3(2):49-54. PubMed ID: 2117268
[TBL] [Abstract][Full Text] [Related]
6. Mechanism(s) regulating inhibition of thymidylate synthase and growth by gamma-L-glutaminyl-4-hydroxy-3-iodobenzene, a novel melanin precursor, in melanogenic melanoma cells.
Prezioso JA; Damodaran KM; Wang N; Bloomer WD
Biochem Pharmacol; 1993 Jan; 45(2):473-81. PubMed ID: 8435097
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues.
Inoue S; Ito S; Wakamatsu K; Jimbow K; Fujita K
Biochem Pharmacol; 1990 Mar; 39(6):1077-83. PubMed ID: 2108682
[TBL] [Abstract][Full Text] [Related]
9. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Miura T; Jimbow K; Ito S
Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
[TBL] [Abstract][Full Text] [Related]
10. Antimelanoma effect of 4-S-cysteaminylcatechol, an activated form of 4-S-cysteaminylphenol.
Inoue S; Hasegawa K; Ito S; Ozeki H; Solano F; Jiménez-Cervantes C; Wakamatsu K; Fujita K
Cancer Res; 1995 Jun; 55(12):2603-7. PubMed ID: 7780975
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
Inoue S; Hasegawa K; Wakamatsu K; Ito S
Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
[TBL] [Abstract][Full Text] [Related]
12. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
13. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
[TBL] [Abstract][Full Text] [Related]
14. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase.
Pankovich JM; Jimbow K; Ito S
Pigment Cell Res; 1990 Sep; 3(3):146-9. PubMed ID: 2127097
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2005; 15(2):87-94. PubMed ID: 16119006
[TBL] [Abstract][Full Text] [Related]
16. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
[TBL] [Abstract][Full Text] [Related]
17. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs.
Thomas PD; Kishi H; Cao H; Ota M; Yamashita T; Singh S; Jimbow K
J Invest Dermatol; 1999 Dec; 113(6):928-34. PubMed ID: 10594732
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion increases tyrosinase activity in human melanoma cells.
del Marmol V; Solano F; Sels A; Huez G; Libert A; Lejeune F; Ghanem G
J Invest Dermatol; 1993 Dec; 101(6):871-4. PubMed ID: 7902381
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.
Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K
Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimelanoma activity of reversed amide analogues of N-acetyl-4-S-cysteaminylphenol.
Nicoll K; Robertson J; Lant N; Kelland LR; Rogers PM; Robins DJ
Oncol Res; 2006; 16(2):97-106. PubMed ID: 16898270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
